《蓝筹业绩》万洲(00288.HK)去年生物公允价值调整前纯利9.7亿美元跌29.4% 派末期息12.5港仙
万洲国际(00288.HK)公布截至去年12月底止全年业绩,生物公允价值调整前的业绩营业额255.89亿美元(下同),按年升6.2%。纯利9.73亿元,按年跌29.4%;每股盈利6.6仙。派每股末期息12.5港仙。
按生物公允价值调整後计算,收入255.89亿元,纯利8.28亿元,按年跌43.48%,每股盈利5.62仙。
公司去年生物公允价值调整前、息税折旧及摊销前利润率为8.9%,按年下跌2.2个百分点、经营利润率6.8%,按年跌1.6个百分点。
在肉制品方面去年集团肉制品的销量下跌2.1%至327.6万公吨,期内收入跌1.3%至121.67亿元,去年集团生猪屠宰总量为4,663.0万头,按年跌13.3%,而猪肉的外部销量为394.6万公吨,按年减少6.6%。(el/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.